The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options-Reference-Cited by-同舟云学术

The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options

Published:2018-12 Issue:6 Volume:69 Page:1365-1370
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Younossi Zobair,Stepanova Maria,Sanyal Arun J.,Harrison Stephen A.,Ratziu Vlad,Abdelmalek Manal F.,Diehl Anna Mae,Caldwell Stephen,Shiffman Mitchell L.,Schall Raul Aguilar,McColgan Bryan,Subramanian G. Mani,Myers Robert P.,Muir Andrew,Afdhal Nezam H.,Bosch Jaime,Goodman Zachary

Publisher

Elsevier BV

Subject

Hepatology

Reference21 articles.

1. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality;Younossi;Hepatology,2011

2. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis;Dulai;Hepatology,2017

3. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease;Caldwell;Hepatology,1999

4. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease;Ong;Liver Transpl,2001

5. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis;Contos;Liver Transpl,2001

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in mortality due to Chronic Liver Diseases (CLD) during the COVID-19 pandemic: Data from the United States’ National Vital Statistics System;PLOS ONE;2024-09-03

2. AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases;Nature Medicine;2024-08-07

3. Metabolic dysfunction‐associated steatotic liver disease has become the most common cause of hepatocellular carcinoma in Sweden: A nationwide cohort study;International Journal of Cancer;2024-07-17

4. Prognostic significance of low hepatic fat content in advanced chronic liver disease: MRI-PDFF insights;Annals of Hepatology;2024-07

5. Updates in characteristics and survival rates of cirrhosis in a nationwide cohort of real‐world U.S. patients, 2003–2021;Alimentary Pharmacology & Therapeutics;2024-05